Why the study?
Does low-dose oral anticoagulation with INR self-management increase the risk of thrombo-embolic events compared to conventional dose INR self-management in patients with mechanical heart valve prostheses?
Does low-dose oral anticoagulation with INR self-management increase the risk of thrombo-embolic events compared to conventional dose INR self-management in patients with mechanical heart valve prostheses?
Low-dose INR self-management in patients with mechanical heart valves does not increase thrombo-embolic risk compared to conventional dosing, though bleeding remains the predominant risk.
Answers are grounded in this paper and cite their sources.
Supports low-dose INR self-management in mechanical valves; extends RCT evidence for reduced-intensity targets.
Data demonstrate that low-dose INR self-management does not increase the risk of thrombo-embolic events compared with conventional dose INR self-management. Even in patients with low INR target range, the risk of bleeding events is still higher than the risk of thrombo-embolism.
No takes yet. Share an insight, caveat, or question.
Koertke et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: